{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-23-036376","form_type":"8-K","ticker":"AGL","cik":"0001831097","company_name":"agilon health, inc.","filed_at":"2023-11-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:30.840889+00:00","generated_at":"2026-06-09T00:55:07.151160+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"agilon health Q3 revenue up 75% to $1.22B, MA members +58%; lowers FY23 MA membership guidance to 384-386K","bullets":["Net loss $31M (unchanged YoY); Adj. EBITDA loss $6M vs. $26M loss last year.","Medical margin $108M (+42% YoY) driven by MA growth; core markets excl. Hawaii saw $111M medical margin.","Completed sale of MDX Hawaii (Oct 31) for undisclosed terms; focus on continental US partner markets.","Updated FY23 guidance: MA members 384-386K (down from 412-415K), revenue $4.31-4.32B, adj. EBITDA $6-18M.","ACO REACH contributed $18M to Adj. EBITDA in Q3; expects $39M for FY23 (up from prior $30-35M)."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-23-036376","json":"https://secwatch.observer/filing/0001628280-23-036376.json","markdown":"https://secwatch.observer/filing/0001628280-23-036376.md","text":"https://secwatch.observer/filing/0001628280-23-036376.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1831097/000162828023036376/0001628280-23-036376-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1831097/000162828023036376/agl-20231102.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-09T00:55:07.151160+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"89bb161f4167bb99c4d3a93613352b8a10697820","claim":"agilon health, inc. reported third quarter ended September 30, 2023 results: revenue $1.22 billion, net income $31 million.","evidence_excerpt":"Total revenue of $1.22 billion increased 75% during the third quarter 2023, compared to $695 million in the third quarter 2022.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1831097/000162828023036376/0001628280-23-036376-index.htm","confidence":0.97,"family_label":"Earnings Releases","details":[{"label":"Period","value":"third quarter ended September 30, 2023"},{"label":"Revenue","value":"$1.22 billion"},{"label":"Net income","value":"$31 million"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}